Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fist Assist is a private medical device company developing and commercializing a wearable intermittent pneumatic compression device designed to dilate arm veins. Its lead product, the Fist Assist FA-1, is intended to support vein enlargement for hemodialysis fistula development and blood-draw/phlebotomy use cases. The company positions the technology as a non-invasive, low-cost approach to improving vascular access preparation, particularly for chronic kidney disease and end-stage renal disease patients. Fist Assist has reported clinical work including the FACT trial and has received FDA Breakthrough Device designation for a presurgical vein-dilation indication, while the FA-1 is marketed in the U.S. as a 510(k)-cleared arm massager and circulation device. The company also appears to commercialize through a distribution relationship with AIROS Medical.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fist Assist Devices.